Unique Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.13M Sell
978
-51
-5% -$60.2K 0.13% 93
2026
Q2
$1.23M Sell
1,029
-327
-24% -$334K 0.14% 85
2026
Q1
$1.25M Sell
1,356
-1,173
-46% -$1.19M 0.17% 75
2025
Q4
$2.72M Sell
2,529
-562
-18% -$537K 0.38% 52
2025
Q3
$2.36M Sell
3,091
-191
-6% -$142K 0.35% 61
2025
Q2
$2.56M Buy
3,282
+184
+6% +$143K 0.41% 56
2025
Q1
$2.56M Buy
3,098
+644
+26% +$536K 0.48% 49
2024
Q4
$1.89M Buy
2,454
+1,053
+75% +$872K 0.39% 50
2024
Q3
$1.24M Buy
1,401
+1,054
+304% +$948K 0.28% 57
2024
Q2
$314K Buy
347
+13
+4% +$10.4K 0.08% 74
2024
Q1
$260K Buy
+334
New +$238K 0.07% 80

Other funds holding LLY

Unique Wealth's LLY Position: Q3 2026 in Review

Unique Wealth reduced its Eli Lilly (LLY) stake by 5% in Q3 2026, selling an estimated $60.2K and leaving 978 shares worth $1.13M. The position accounts for 0.13% of the portfolio, ranked #93.

Unique Wealth first reported a position in LLY in Q1 2024 and has held it in 11 quarters since. The position peaked at $2.72M in Q4 2025. 2,029 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Unique Wealth held 978 shares of Eli Lilly worth $1.13M as of Q3 2026.
  • Unique Wealth sold 51 Eli Lilly shares in Q3 2026, an estimated $60.2K.
  • Eli Lilly made up 0.13% of Unique Wealth's portfolio in Q3 2026, its #93 holding.
  • Unique Wealth first reported a position in Eli Lilly in Q1 2024 and has held it in 11 quarters since.
  • Unique Wealth's Eli Lilly position peaked at $2.72M in Q4 2025.
  • 2,029 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Unique Wealth's 13F filing for Q3 2026, filed 16 Oct 2026.